Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

InMed Pharmaceuticals (INM) Asset Utilization Ratio: 2023-2025

Historic Asset Utilization Ratio for InMed Pharmaceuticals (INM) over the last 3 years, with Jun 2025 value amounting to 0.36.

  • InMed Pharmaceuticals' Asset Utilization Ratio fell 25.51% to 0.33 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.33, marking a year-over-year decrease of 25.51%. This contributed to the annual value of 0.36 for FY2025, which is 1.72% up from last year.
  • InMed Pharmaceuticals' Asset Utilization Ratio amounted to 0.36 in FY2025, which was up 1.72% from 0.35 recorded in FY2024.
  • In the past 5 years, InMed Pharmaceuticals' Asset Utilization Ratio ranged from a high of 0.36 in FY2025 and a low of 0.31 during FY2023.
  • Over the past 3 years, InMed Pharmaceuticals' median Asset Utilization Ratio value was 0.35 (recorded in 2024), while the average stood at 0.34.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first grew by 15.31% in 2024, then decreased by 1.72% in 2025.
  • InMed Pharmaceuticals' Asset Utilization Ratio (MRY) stood at 0.31 in 2023, then grew by 15.31% to 0.35 in 2024, then grew by 1.72% to 0.36 in 2025.
  • Its Asset Utilization Ratio was 0.36 in FY2025, compared to 0.35 in FY2024 and 0.31 in FY2023.